Anthony N Muiru1,2, Prossy Bibangambah3, Linda Hemphill1, Ruth Sentongo3, June-Ho Kim4, Virginia A Triant1, David R Bangsberg1,5, Alexander C Tsai3,6, Jeffrey N Martin7, Jessica E Haberer1, Yap Boum8, Jorge Plutzky4, Peter W Hunt7, Samson Okello3, Mark J Siedner1,3. 1. Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 2. Currently, Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA. 3. Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. 4. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 5. Currently, Oregon Health Sciences University-Portland State University School of Public Health, Portland, OR. 6. Chester M. Pierce, MD, Division of Global Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 7. Epidemiology and Biostatistics, University of California, San Francisco, CA. 8. Epicentre Research Base, Mbarara, Uganda.
Abstract
BACKGROUND: The utility and validity of cardiovascular diseases (CVD) risk scores are not well studied in sub-Saharan Africa. We compared and correlated CVD risk scores with carotid intima media thickness (c-IMT) among HIV-infected and uninfected people in Uganda. METHODS: We first calculated CVD risk using the (1) Framingham laboratory-based score; (2) Framingham nonlaboratory score (FRS-BMI); (3) Reynolds risk score; (4) American College of Cardiology and American Heart Association score; and (5) the Data collection on Adverse Effects of Anti-HIV Drugs score. We then compared absolute risk scores and risk categories across each score using Pearson correlation and kappa statistics, respectively. Finally, we fit linear regression models to estimate the strength of association between each risk score and c-IMT. RESULTS: Of 205 participants, half were females and median age was 49 years [interquartile range (IQR) 46-53]. Median CD4 count was 430 cells/mm (IQR 334-546), with median 7 years of antiretroviral therapy exposure (IQR 6.4-7.5). HIV-uninfected participants had a higher median systolic blood pressure (121 vs. 110 mm Hg), prevalent current smokers (18% vs. 4%, P = 0.001), higher median CVD risk scores (P < 0.003), and greater c-IMT (0.68 vs. 0.63, P = 0.003). Overall, FRS-BMI was highly correlated with other risk scores (all rho >0.80). In linear regression models, we found significant correlations between increasing CVD risk and higher c-IMT (P < 0.01 in all models). CONCLUSIONS: In this cross-sectional study from Uganda, the FRS-BMI correlated well with standard risk scores and c-IMT. HIV-uninfected individuals had higher risk scores than HIV-infected individuals, and the difference seemed to be driven by modifiable factors.
BACKGROUND: The utility and validity of cardiovascular diseases (CVD) risk scores are not well studied in sub-Saharan Africa. We compared and correlated CVD risk scores with carotid intima media thickness (c-IMT) among HIV-infected and uninfected people in Uganda. METHODS: We first calculated CVD risk using the (1) Framingham laboratory-based score; (2) Framingham nonlaboratory score (FRS-BMI); (3) Reynolds risk score; (4) American College of Cardiology and American Heart Association score; and (5) the Data collection on Adverse Effects of Anti-HIV Drugs score. We then compared absolute risk scores and risk categories across each score using Pearson correlation and kappa statistics, respectively. Finally, we fit linear regression models to estimate the strength of association between each risk score and c-IMT. RESULTS: Of 205 participants, half were females and median age was 49 years [interquartile range (IQR) 46-53]. Median CD4 count was 430 cells/mm (IQR 334-546), with median 7 years of antiretroviral therapy exposure (IQR 6.4-7.5). HIV-uninfectedparticipants had a higher median systolic blood pressure (121 vs. 110 mm Hg), prevalent current smokers (18% vs. 4%, P = 0.001), higher median CVD risk scores (P < 0.003), and greater c-IMT (0.68 vs. 0.63, P = 0.003). Overall, FRS-BMI was highly correlated with other risk scores (all rho >0.80). In linear regression models, we found significant correlations between increasing CVD risk and higher c-IMT (P < 0.01 in all models). CONCLUSIONS: In this cross-sectional study from Uganda, the FRS-BMI correlated well with standard risk scores and c-IMT. HIV-uninfected individuals had higher risk scores than HIV-infected individuals, and the difference seemed to be driven by modifiable factors.
Authors: Rod Jackson; Carlene M M Lawes; Derrick A Bennett; Richard J Milne; Anthony Rodgers Journal: Lancet Date: 2005 Jan 29-Feb 4 Impact factor: 79.321
Authors: Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Annelot F Schoffelen; Eric de Groot; Hugo A Tempelman; Frank L J Visseren; Andy I M Hoepelman; Roos E Barth Journal: Clin Infect Dis Date: 2015-07-27 Impact factor: 9.079
Authors: Lindsay M Jaacks; Mohammed K Ali; John Bartlett; Gerald S Bloomfield; William Checkley; Thomas A Gaziano; Douglas C Heimburger; Sandeep P Kishore; Racquel E Kohler; Kasia J Lipska; Olivia Manders; Christine Ngaruiya; Robert Peck; Melissa Burroughs Pena; David A Watkins; Karen R Siegel; K M Venkat Narayan Journal: Ann Intern Med Date: 2015-08-25 Impact factor: 25.391
Authors: Mark J Siedner; June-Ho Kim; Ruth Sentongo Nakku; Linda Hemphill; Virginia A Triant; Jessica E Haberer; Jeffrey N Martin; Yap Boum; Douglas S Kwon; Alexander C Tsai; Peter W Hunt; Samson Okello; David R Bangsberg Journal: AIDS Date: 2016-02-20 Impact factor: 4.177
Authors: Ben Alencherry; Geoffrey Erem; Grace Mirembe; Isaac Ssinabulya; Chun-Ho Yun; Chung-Lieh Hung; Mark J Siedner; Marcio Bittencourt; Cissy Kityo; Grace A McComsey; Chris T Longenecker Journal: Open Heart Date: 2019-05-22
Authors: Frank Mubiru; Barbara Castelnuovo; Steven J Reynolds; Agnes Kiragga; Harriet Tibakabikoba; Noela Clara Owarwo; Andrew Kambugu; Mohammed Lamorde; Rosalind Parkes-Ratanshi Journal: PLoS One Date: 2021-01-28 Impact factor: 3.240
Authors: Rebecca F Gilbert; Cody Cichowitz; Prossy Bibangambah; June-Ho Kim; Linda C Hemphill; Isabelle T Yang; Ruth N Sentongo; Bernard Kakuhikire; David C Christiani; Alexander C Tsai; Samson Okello; Mark J Siedner; Crystal M North Journal: BMC Pulm Med Date: 2022-01-05 Impact factor: 3.317
Authors: Rocio Enriquez; Robert Ssekubugu; Anthony Ndyanabo; Gaetano Marrone; Bruna Gigante; Larry W Chang; Steven J Reynolds; Fred Nalugoda; Anna Mia Ekstrom; Nelson K Sewankambo; David M Serwadda; Helena Nordenstedt Journal: J Int AIDS Soc Date: 2022-04 Impact factor: 5.396
Authors: Katherine Kentoffio; Matthew S Durstenfeld; Mark J Siedner; Cissy Kityo; Geoffrey Erem; Isaac Ssinabulya; Brian Ghoshhajra; Marcio S Bittencourt; Chris T Longenecker Journal: Int J Cardiol Cardiovasc Risk Prev Date: 2022-06-08
Authors: Titus Msoka; Josephine Rogath; Gary Van Guilder; Gibson Kapanda; Yvo Smulders; Marceline Tutu van Furth; John Bartlett; Michiel van Agtmael Journal: HIV AIDS (Auckl) Date: 2021-06-03
Authors: Mark J Siedner; Prossy Bibangambah; June-Ho Kim; Alexander Lankowski; Jonathan L Chang; Isabelle T Yang; Douglas S Kwon; Crystal M North; Virginia A Triant; Christopher Longenecker; Brian Ghoshhajra; Robert N Peck; Ruth N Sentongo; Rebecca Gilbert; Bernard Kakuhikire; Yap Boum; Jessica E Haberer; Jeffrey N Martin; Russell Tracy; Peter W Hunt; David R Bangsberg; Alexander C Tsai; Linda C Hemphill; Samson Okello Journal: J Am Heart Assoc Date: 2021-06-05 Impact factor: 6.106